Business · 30/01/2020
FDA Announces Final Guidance for Human Gene Therapy for Hemophilia
The FDA has released a final guidance document outlining recommendations for the development of human gene therapy products for treating hemophilia, including clinical trial design and preclinical considerations.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →